Dopaminergic impact on cortical excitability in humans

Reviews in the Neurosciences

Volumn 21, Issue 4, 2010, Pages 289-298

  Nitsche, Michael A ^a   Monte Silva, Katia ^a   Kuo, Min Fang ^a   Paulus, Walter ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Dopamine; Excitability; Human; Motor cortex; Motor evoked potentials; Transcranial magnetic stimulation

Indexed keywords

AMANTADINE; APOMORPHINE; BIPERIDEN; BROMOCRIPTINE; CABERGOLINE; CLOZAPINE; DOPAMINE; DOPAMINE RECEPTOR; HALOPERIDOL; LEVODOPA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OLANZAPINE; PERGOLIDE; QUETIAPINE; SELEGILINE; SULPIRIDE;

ALZHEIMER DISEASE; BRAIN CORTEX; CORTICAL SYNCHRONIZATION; DOPAMINERGIC SYSTEM; ELECTROENCEPHALOGRAM; HUMAN; MOTOR CORTEX; NERVE CELL NETWORK; NERVE EXCITABILITY; NEUROMODULATION; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SPINAL NERVE; STROKE;

EID: 78349281876     PISSN: 03341763     EISSN: None     Source Type: Journal    
DOI: 10.1515/REVNEURO.2010.21.4.289     Document Type: Review

References (55)

1. Abbruzzese, Trompetto C. Clinical and research methods for evaluating cortical excitability. J Clin Neurophysiol 2002;19:307-21.
2. Bares M, Kanovský P, Klajblová H, Rektor I. Intracortical inhibition and facilitation are impaired in patients with early Parkinson's disease: a paired TMS study. Eur J Neurol 2003;10:385-9. (Pubitemid 41754758)
3. Blanpied TA, Clarke RJ, Johnson JW. Amantadine inhibits NMDA receptors by accelerating channel closure during channel block. J Neurosci 2005;25: 3312-22.
4. Boroojerdi B, Battaglia F, Muellbacher W, Cohen LG. Mechanisms influencing stimulus-response properties of the human corticospinal system. Clin Neurophysiol 2001;112:931-7. (Pubitemid 32406270)
5. Briand LA, Gritton H, Howe WM, Young DA, Sarter M. Modulators in concert for cognition: modulator interactions in the prefrontal cortex. Prog Neurobiol 2007;83:69-91. (Pubitemid 47464694)
6. Carlsoon A. The occurrence, distribution and physiological role of catecholamines in the nervous system. Pharmacol Rev 1959;11:490-3.
7. Chen R. Studies of human motor physiology with transcranial magnetic stimulation. Muscle Nerve 2000;Suppl 9:S26-S32.
8. Chen R, Samii A, Caños M, Wassermann EM, Hallett M. Effects of phenytoin on cortical excitability in humans. Neurology 1997;49:881-3. (Pubitemid 27428043)
9. Daskalakis ZJ, George TP. Clozapine, GABA(B), and the treatment of resistant schizophrenia. Clin Pharmacol Ther 2009;86:442-6.
10. Daskalakis ZJ, Christensen BK, Chen R, Fitzgerald PB, Zipursky RB, Kapur S. Effect of antipsychotics on cortical inhibition using transcranial magnetic stimulation. Psychopharmacology (Berl) 2003;170:255-62. (Pubitemid 37491604)
11. Daskalakis ZJ, Christensen BK, Chen R, Fitzgerald PB, Zipursky RB, Kapur S. Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation. Arch Gen Psychiatry 2002;59:347-54. (Pubitemid 34275253)
12. Daskalakis ZJ, Christensen BK, Fitzgerald PB, Moller B, Fountain SI, Chen R. Increased cortical inhibition in persons with schizophrenia treated with clozapine. J Psychopharmacol 2008;22:203-9. (Pubitemid 351322858)
13. Davey NJ, Puri BK, Lewis HS, Lewis SW, Ellaway PH. Effects of antipsychotic medication on electromyographic responses to transcranial magnetic stimulation of the motor cortex in schizophrenia. J Neurol Neurosurg Psychiatry 1997;63:468-73.
14. Di Lazzaro V, Oliviero A, Profice P, Pennisi MA, Pilato F, Zito G, et al. Ketamine increases motor cortex excitability to transcranial magnetic stimulation. J Physiol 2003;547:485-96. (Pubitemid 36304982)
15. Durstewitz D, Seamans JK. The dual-state theory of prefrontal cortex dopamine function with relevance to catechol-o-methyltransferase genotypes and schizophrenia. Biol Psychiatry 2008;64: 739-9.
16. Eichhammer P, Wiegand R, Kharraz A, Langguth B, Binder H, Hajak G. Cortical excitability in neuroleptic-naive first-episode schizophrenic patients. Schizophr Res 2004;67:253-9. (Pubitemid 38251456)
17. Einhorn LC, Gregerson KA, Oxford GS. D2 dopamine receptor activation of potassium channels in identified rat lactotrophs:whole-cell and single-channel recording. J Neurosci 1991;11: 3727-37.
18. Fitzgerald PB, Brown TL, Daskalakis ZJ, Kulkarni J. A transcranial magnetic stimulation study of the effects of olanzapine and risperidone on motor cortical excitability in patients with schizophrenia. Psychopharmacology (Berl) 2002; 162:74-81 (Pubitemid 34639560)
19. Gaspar PA, Bustamante ML, Silva H, Aboitiz F. Molecular mechanisms underlying glutamatergic dysfunction in schizophrenia: therapeutic implications. J Neurochem 2009;111:891-900.
20. Gorsler A, Liepert J. Influence of cabergoline on motor excitability in patients with restless legs syndrome. J Clin Neurophysiol 2007;24:456-60. (Pubitemid 350307354)
21. Hess CW, Mills KR, Murray NM. Responses in small hand muscles from magnetic stimulation of the human brain. J Physiol (Lond) 1987;388:397-419.
22. Huang YY, Kandel ER. Postsynaptic induction and PKA-dependent expression of LTP in the lateral amygdala. Neuron 1998;21:813-25.
23. Ilic TV, Meintzschel F, Cleff U, Ruge D, Kessler KR, Ziemann U. Short-interval paired-pulse inhibition and facilitation of human motor cortex: the dimension of stimulus intensity. J Physiol 2002;545:153-67. (Pubitemid 35386133)
24. Iversen SD, Iversen LL. Dopamine: 50 years in perspective: Trends Neurosci 2007;30:188-193.
25. Kimiskidis VK, Papagiannopoulos S, Sotirakoglou K, Kazis DA, Kazis A, Mills KR. Silent period to transcranial magnetic stimulation: constmction and properties of stimulus-response curves in healthy volunteers. Exp Brain Res 2005; 163:21-31.
26. Korchounov A, Ilic TV, Ziemann U. TMS-assisted neurophysiological profiling of the dopamine receptor agonist cabergoline in human motor cortex. J Neural Transm 2007;114:223-9. (Pubitemid 46147160)
27. Langguth B, Eichhammer P, Spranz C, Landgrebe M, Frick U, Sand P, Hajak G. Modulation of human motor cortex excitability by quetiapine. Psychopharmacology (Berl) 2008;196:623-9.
28. Lewis DA, Hashimoto T. Deciphering the disease process of schizophrenia: the contribution of cortical GABA neurons. Int Rev Neurobiol 2007; 78:109-31.
29. Martorana A, Stefani A, Palmieri MG, Esposito Z, Bemardi G, Sancesario G, et al. L-dopa modulates motor cortex excitability in Alzheimer's disease patients. J Neural Transm 2008;115:1313-9.
30. Mattson MP. Glutamate and neurotrophic factors in neuronal plasticity and disease. Ann NY Acad Sci 2008;1144:97-112.
31. Mehta MA, Riedel WJ. Dopaminergic enhancement of cognitive function. Curr Pharm Des 2006; 12:2487-500.
32. Mohammadi B, Krampfl K, Petri S, Bogdanova D, Kossev A, Bufler J, Dengler R. Selective and nonselective benzodiazepine agonists have different effects on motor cortex excitability. Muscle Nerve 2006;33:778-84. (Pubitemid 43856795)
33. Nardone R, Ausserer H, Bratti A, Covi M, Lochner P, Marth R, et al. Cabergoline reverses cortical hyperexcitability in patients with restless legs syndrome. Acta Neurologica Scandinavica 2006;114:244-9. (Pubitemid 44337242)
34. Neusch C, Böhme V, Riesland N, Althaus M, Moser A. The dopamine D2 receptor agonist alpha-dihydroergocryptine modulates voltage-gated sodium channels in the rat caudate-putamen. J Neural Transm 2000;107:531-41. (Pubitemid 30251737)
35. Nitsche MA, Kuo M-F, Grosch J, Bergner C, Monte-Silva K, Paulus W. D1-receptor impact on neuroplasticity in humans. J Neurosci 2009;29: 2648-53.
36. Nitsche MA, Lampe C, Antal A, Liebetanz D, Lang N, Tergau F, Paulus W. Dopaminergic modulation of DC-induced neuroplasticity in the human motor cortex. Eur J Neurosci 2006;23: 1651-7.
37. Paulus W, Classen J, Cohen LG, Di Lazzaro V, Nitsche M, Pascual-Leone et al. State of the art: Pharmacological effects on cortical excitability measures tested by Transcranial Magnetic Stimulation. Brain Stimu 2008;1:151-63
38. Pierantozzi M, Palmieri MG, Marciani MG, Bemardi G, Giacomini P, Stanzione P. Effect of apomorphine on cortical inhibition in Parkinson's disease patients: a transcranial magnetic stimulation study. Exp Brain Res 2001;141:52-62. (Pubitemid 32947219)
39. Priori A, Berardelli A, Inghilleri M, Accomero N, Manfredi M. Motor cortical inhibition and the dopaminergic system. Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson's disease and drug-induced parkinsonism. Brain 1994;117:317-323.
40. Restemeyer C, Weiller C, Liepert J. No effect of a levodopa single dose on motor performance and motor excitability in chronic stroke. A double-blind placebo-controlled cross-over pilot study. Restor Neurol Neurosci 2007;25:143-50.
41. Robbins TW, Roberts AC. Differential regulation of fronto-executive function by the monoamines and acetylcholine. Cereb Cortex 2007;17 Suppl 1:i151-60.
42. Schwenkreis P, Liepert J, Witscher K, Fischer W, Weiller C, Malin JP, Tegenthoff M. Riluzole suppresses motor cortex facilitation in correlation to its plasma level. Exp Brain Res 2000;135:293-9.
43. Seamans JK, Gorelova N, Durstewitz D, Yang CR. Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons. J Neurosci 2001;21:3628-38. (Pubitemid 32422827)
44. Seamans JK, Yang CR. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 2004;74:1-58.
45. Sohn YH, Kaelin-Lang A, Jung HY, Hallett M. Effect of levetiracetam on human corticospinal excitability. Neurology 2001;57:858-63. (Pubitemid 32845508)
46. Stefani A, Spadoni F, Martorana A, Lavaroni F, Martella G, Sancesario G, et al. D2-mediated modulation of N-type calcium currents in rat globus pallidus neurons following dopamine denervation. Eur J Neurosci 2002;15:815-25. (Pubitemid 35469166)
47. Tergau F, Wischer S, Somal HS, Nitsche MA, Mercer AJ, Paulus W, et al. Relationship between lamotrigine oral dose, serum level and its inhibitory effect on CNS: insights from transcranial magnetic stimulation. Epilepsy Res 2003; 56:67-77. (Pubitemid 37177056)
48. Wobrock T, Schneider M, Kadovic D, Schneider-Axmann T, Ecker UK, Retz W, et al. Reduced cortical inhibition in first-episode schizophrenia. Schizophr Res 2008;105:252-61.
49. Zheng P, Zhang XX, Bunney BS, Shi WX. Opposite modulation of cortical N-methyl-D-aspartate receptor-mediated responses by low and high concentrations of dopamine. Neuroscience 1999;91:527-35. (Pubitemid 29193262)
50. Zhou FM, Hablitz JJ. Dopamine modulation of membrane and synaptic properties of interneurons in rat cerebral cortex. J Neurophysiol 1999;81: 967-76.
51. Ziemann U. TMS induced plasticity in human cortex. Rev Neurosci 2004;15:253-66. (Pubitemid 39388336)
52. Ziemann U, Lönnecker S, Steinhoff BJ, Paulus W. The effect of lorazepam on the motor cortical excitability in man. Exp Brain Res 1996;109:127-35.
53. Ziemann U, Tergau F, Wassermann EM, Wischer S, Hildebrandt J, Paulus W. Demonstration of facilitatory I-wave interaction in the human motor cortex by paired transcranial magnetic stimulation. J Physiol (Lond) 1998;511:181-90.
54. Ziemann U, Chen R, Cohen LG, Hallett M. Dextromethorphan decreases the excitability of the human motor cortex. Neurology 1998;51: 1320-4.
55. Ziemann U, Tergau F, Bruns D, Baudewig J, Paulus W. Changes in human motor cortex excitability induced by dopaminergic and antidopaminergic drugs. Electroencephalogr Clin Neurophysiol 1997;105:430-7.